Carboplatin + PEMBROLIZUMAB + Paclitaxel for squamous cell carcinoma of head and neck

A treatment and a condition, followed through the public trial records. Not medical advice. How a status is set

Phase 2 trial. Mid-stage trial in people. As of 19 Nov 2026, from 1 registered trial.

Why this status

  1. 15 Jun 2022: Trial registered, NCT05420948
  2. 17 Oct 2022: Trial started, NCT05420948

The trials

NCT05420948: A Study of Pembrolizumab in Combination With Chemotherapy for Head and Neck Cancer

State
Under way
Phase
Phase 2
People
30 planned
Started
17 Oct 2022
Primary completion
1 Dec 2026
Arms
Group 2: Participants Who Receive Pembrolizumab + Chemotherapy with Carboplatin and Paclitaxel
Results
None posted
  1. 15 Jun 2022: Trial registered
  2. 17 Oct 2022: Trial started

How the status changed

  1. 19 Nov 2026: First set: Phase 2 trial

Registries searched: ClinicalTrials.gov, through 17 Nov 2026.